Tujuan Dilakukan penilaian terhadap keberhasilan kehamilan pada penanganan dengan In Vitro Maturation (IVM) pada kasus-kasus PCOS (Poly Cystic Ovary Syndrome) Methods This paper is a report of 7 cases in Indonesia that used the newly developed technique. There were 7 cases confi rmed PCOS, in which 1 patient with a history of OHSS (Ovary Hyper Stimulation Syndrome) in a previous IVF procedure and 1 patient with PCOS characteristics, suspected hyper responder, in the Family Hospital from January to May of 2009. Follicular induction was performed with a minimum dose, primming with HCG 10.000 IU, on the 10th day and 40 hours later ovum pick up was performed, followed by in vitro maturation. Subsequently, insemination was performed and the inseminated follicle was assessed. Well qualifi ed embryos then transferred them into the uterus. We then performed assessment of pregnancy biochemically, by the presence of embryonic sac and embryonic heart beat.
Compared to normal women, PCOS have a larger tendency to catch the side effect of OHSS. It is believed that the stimulation of ovulation may induce ovarian and endometrial cancer. 1 Besides, stimulation with gonadotropin and GnRH agonist can be costly. 2 Many scientists have performed IVF (in vitro fertilization) in the normal cycle because of the simplicity of the method, limited side effects, low cost and considering the patient's comfort. Although the normal cycle provides limited success due to the low number of oocytes gained, the success rate of pregnancy is 46% after the procedure has been repeated 4 times. 3 Therefor, it has been considered to perform the IVF technique in the normal cycle with in vitro maturation. By this way, even without costly stimulation the patient still has a good chance of achieving pregnancy.
Nonetheless, this technique should only be applied in certain cases considering the specifi c conditions of each case, to optimize the success of pregnancy. Further research must be performed to fi nd the optimum conditions for cultivation to improve the implantation rate of oocytes that are matured in vitro.
This article will describe the experience of performing the IVM program in PCOS cases and predicted hyperresponders.
The IVM technique was fi rst developed in 1940. 4 It was performed until 1960 when a technique was develop to obtain an oocyte from a de Graaf follicle through laparoscopy. 5 Cha in 1991, and Trounson in 1994, announced the success of achieving pregnancy through IVM in PCOS cases. 6, 7 PCOS patients are good candidates for IVM because of the number of antral follicles in this case group. In general, 30 to 35% of PCOS patients will achieve and 10 to 15% in PCOS patients. 8, 9 Thus, IVM was performed to lower costs, to prevent OHSS in PCOS patients, and to simplify the procedure of IVF.
10,11

METHODS
All the cases were collected in the Family Hospital, Jakarta from April 2008 to April 2009. This is a preliminary report of a prospective study, assessing the rate of in vitro maturation, fertilization, the formation of embryo, and ultimately, pregnancy.
The cases used in this study were 7 infertility cases with PCOS, established through the Rotterdam criteria, and one case with a history of OHSS (ovarian hyperstimulation syndrome). HSG was performed to observe uterine cavity in cycle before the program was started.
Hormonal measurements were taken for FSH, LH, E2 and testosterone. On the sexual partner we performed sperm analysis and sperm recovery test. We injected the patient with gonadotropin 150 IU in days 8, 9, and 10 of the menstrual cycle, and priming with HCG 10.000 IU. On the 11th day and 40 hours later we performed OPU (Ovum Pick Up) During OPU we measured the diameter of the follicle. OPU was performed using a combination of size 19 g aspiration needle and a set of aspiration needles with the outer needle sized 17 g and inner needle sized 20 g with a suction pressure of 80 to 110 mmHg.
Basic USG
USG was performed on the second day of the menstrual cycle to observe the uterus and to determine the number of BAF (basal antral follicle) in both ovaries. If the patient has an irregular cycle, then progesteron preparation (Provera 5 mg, twice daily for fi ve days) was used to induce menstruation.
The next USG was performed on the 6th and 9th days to measure the thickness of the endometrium and to ensure the presence of a developing follicle. (Figure1) Injections of 150 IU gonadotropin was given to the patients on days 8, 9, and 10. On the 11th day, we gave an injection of 10.000 IU HCG. In the case of the hyperresponder whose follicle was 11 mm on the 9th day, HCG priming was performed on the 10th day. 
HCG Administration
Patients were given 10.000 IU hCG 36 hours prior to OPU. OPU was performed between day 10-14, depending on the endometrial thickness (must be 6 mm or more) and the follicular diameter. This is very important to prevent spontaneous ovulation.
OPU (Ovum pick up)
One day before the OPU, a medium was prepared: Synvitro fl uch, LAG, IVM, FSH solution, hCG solution, stored in 37 o Celcius and 5% CO 2 . Obtained oocytes were incubated in LAG medium for 2 to 3 hours, then transferred to fi nal IVM maturation medium, consisted of IVM medium, patient serum, and FSH solution. hCG solution was incubated for 24 to 48 hours. The next day, the oocyte was denuded, then stored at ISM1 medium for 2 hours. Oocytes that fulfi ll requirements underwent ICSI (intracytoplasmic sperm injection).
The needles used for OPU were a combination of size 19 g aspiration needle and a set of aspiration needles, outer 17 g needle, inner 20 g needle, with a suction pressure of 80 to 110 mmHg. All visible follicles were extracted while the patient underwent general anesthesia.
Method of locating oocytes
Follicular solution was transferred to a petri dish then examined under a stereo miscroscope. Follicular solution was strained through a cellular sieve of 70 um, then diluted by a washing solution, then transferred to a petri dish (falcon 60 x 15 mm). All procedures were performed on a plate of 37 o C.
Maturation procedure of oocyte 12, 13, 14 Medium was prepared at least one hour ahead of OPU and placed in an incubator of 30 o C. Three petri dishes were required (falcon 35 x 10 mm) consisting of 2-2,5 ml of oocyte washing solution under mineral oil for each patient. For each patient, we also prepared, 50 ml Falcon fi lled with 25-50 ml of oocyte washing solution in an incubator. The oocytes were then gathered in a 10 ml tube fi lled with washing medium mixed with 2-3 ml. 2 IU/ml heparin. Other than the usual medium, we also used 0,9% NaCl mixed with 2 IU/ml of heparin.
Immature oocytes were incubated in a tissue culture dish (falcon 60 x 15 ml, consisting of 1 ml maturation medium with a fi nal concentration of 75 mIU/ml of FSH and 75 mIU/ml of LH in 30 o C with a fl ow of 5% CO2 and 95% air or of three gasses 90 % N2, 5 % CO2, and 5 % O2 with a humidity of 100 %. This medium was prepared at least 2 years prior to OPU.
Ovum pick up was performed 40 hours after hCG administration under general anesthesia. OPU was performed using COOK ovum aspiration needle size 19 g or COOK ovum aspiration needle set consisting of 17 g outer needle and 20 g inner needle. (Figure 2 and 3) Needle selection depends on the condition of the follicle. In patients with a history of OHSS and hyperresponder, where the diameter of most follicles were 9 to 11 mm, we used a 19g needle. But in patients with PCOS, in which most of the diameter of follicles were 6 to 8 mm, we used a needle set of 17 g and 21 g needles. In the latter condition, the follicles were fi rst punctures with the 17 g outer needle to the adjacent of the target follicle, then the 21 g inner needle was inserted into the follicle and the follicular solution was aspirated. For the next follicle, the inner needle was then retracted into the outer needle that was manipulated in such a way that it reaches the side of the next follicle.
In cases where the vaginal walls were considered thick and rigid, we used the outer and inner needle set, because the 19 g needle was very pliable making it diffi cult to puncture the vaginal wall. During perforation, pressure to the abdominal wall was applied by a nurse to help fi xate the ovary.
Rinsing of the needles, or tubing, after two or three aspirations of the follicular solution was very important. Rinsing was performed by using NaCl solution mixed with heparin to prevent coagulation in the lumen of the needle. Aspirated solutions were immediately brought to the laboratory to observe for oocyte cumulus complex. (Figure 4 ,5, and 6)
RESULTS
The fi rst patient, 31 years old, has been infertile for 8 years and has underwent induction of ovulation 8 times, and failed. Physical examination showed body weight 88 kg, height 160 cm, BMI 34.5, with signs of hirsutism. Ultrasonographic examination on the second day of menstruation showed: uterus within normal limits, 40 basal antral follicles (BAF) in both ovaries. Hormonal examination results showed: FSH 4,5 mIU/ml , LH 3,0 mIU/ml, E2 <20 pg/ml dan testoterone 3,8 ng/ dl. Sperm analysis of the husband were within normal range with sperm recovery of 10 million/ml.
Out of 11 mature oocytes that underwent ICSI, 8 were fertilized, and developed into 8 embryos. Four days after OPU we transferred 4 embryos. The patient did not become pregnant and menstruated.
The second patient was 30 years old, with a history of blighted ovum three years before. Screening revealed a non patent right tube and appearance of policystic ovaries with more than 20 BAFs. Hormonal examination showed FSH 6,0 mIU/ml , LH 3,9 mIU/ml, E2 <20 pg/ ml. Sperm analysis of the husband were within normal range with sperm recovery of 4.5 million/ml. Upon OPU the follicle was 7.4 mm to 12 mm in diameter.
In this patients we obtained 9 immature oocytes and retained 8 oocytes post maturation that were viable for ICSI. Fertilization occured in 5 oocytes and developed into 3 embryos of excellent quality. The three embryos were transferred and given luteal support with vaginal progesteron. The patient became pregnant with one gestational sac, an apparent yolk sac, fetal pole and pulsation. (Figure 7 ) The third patient was 42 years old with a history of OHSS in a previous IVF procedure, the patient did become pregnant but miscarried. Upon examination on the second day of menstruation we found 11 BAFs. Sperm analysis of the husband showed a sperm count of less than 100.000 ml. Upon OPU we obtained 7 immature oocytes, to which we induced maturation. Upon maturation, we obtained 6 oocytes that were adequate for ICSI. Fertilization occured in 4 oocytes and developed into 4 embryos. Three embryos were transferred and given luteal phase support with vaginal progesteron. The patient failed to be pregnant.
The fourth patient was 31 year old with a history of abortion. Screening revealed 16 BAFs (PCO), FSH 6,2 mIU/ml, LH 5,4 mIU/ml, E2 23,2 pg/ml. Sperm analysis of the husband revealed sperm recovery of less than 100.000 ml. Upon OPU, the follicular diameter was 5 mm, and to 12 mm. From this patients we obtained 19 oocytes, and 13 oocytes post-maturation that were adequate for ICSI. Out of those, 12 oocytes became fertilized and 11 developed into embryos. Four embryos were frozen and three were transferred and given luteal support using vaginal progesteron. The attempt for pregnancy was not successful.
The fi fth patient was 28 year old with 4 years of primary infertility and a history of failed IVF. Screening revealed bilateral non patent tubes and the appearance of PCO ovaries with 25 BAFs. Sperm analysis of the husband were within normal range with sperm recovery of 3 million/ml. From this patients we obtained 13 immature oocytes, performed maturation, and obtained 12 oocytes ready for ICSI. Fertilization occured in 8 oocytes and 7 of them developed into embryos. Two embryos were transferred. The patient was pregnant and fetal pulsation was recorded on the 6th week of pregnancy.
The sixth patient was 31 years old, with a history of four failed IVFs. The second IVF was successful but was a BO and the latest IVF showed signs of OHSS. The patient had two non patent tubes. After ICSI four oocytes were fertilized and three embryos developed. These three were tranferred, but the patient failed to be pregnant.
The seventh patient was 31 year old who previously had been pregnant but miscarried. She has been married for three years, and has a menstrual cycle of 36 to 48 days. Sperm analysis were within normal limits with sperm recovery of 2 million/ml. We counted 24 BAFs. Upon OPU the follicular diameter was to 9 mm. In this patient we obtained 7 immature oocytes on which we performed maturation. Post maturation we obtained 7 oocytes that were ready for ICSI. Post ICSI, three oocytes were fertilized and developed into 3 embryos. These three were transferred, but the patient failed to be pregnant Table 1 shows that out of the seven patients who received the IVM procedures, two patients had obvious PCOS, 1 patient with a history of OHSS in a previous IVF procedure. Although hormonally there were no obvious signs of PCOS (less than 23.2 pg/ml), all patients had BAF (more than 11) and all patients fulfi lled the Rotterdam criteria. These are typical of hyperresponders who run the risk of developing OHSS once stimulated through the usual protocol (long or short protocol).
DISCUSSION
Out of the seven spouses, two cases were oligospermia. Totally in this series there were 156 BAFs, with a mean of 22 follicles and a mean of 12 oocytes. This meant that the OPU was successful in 56% of the cases, which was quite a feat considering that the follicular diameters were between 5.3 to 10 mm, and that this was the fi rst OPU attempt on smaller follicles.
Out of 59 mature oocytes, all underwent ICSI, from which 41 (69 %) embryos developed. Out of 7 patients who received transfer, two (28.6%) became pregnant. Although the population size is yet to be expanded, this is an encouraging preliminary compared to the achievements of other countries. Results from other countries based on the cilinical pregnancy rates were: France 18%, Japan 26.8%, Scandinavia (Sweden and Finland) 22%, Vietnam 27.6% and Canada 28%. 15, 16 Out of 81 oocytes that were matured in vitro, we harvested 59 (73 %) mature oocytes. This shows that the in vitro maturation technique was quite successful. This fi nding showed that IVM as an IVF (In Vitro Fertilization) procedure was successfully performed in Indonesia. In the future, IVM will be the fi rst choice for patients who are willing to undergo reproductive technology, for the following reasons: 1) simplifi ed procedure; 2) cost effi ciency; 3) avoidance of OHSS.
Other advantages of IVM are the preservation of oocytes or ovarian tissue in cancer cases, more comfortable for the patient because it is less pain due to injections and the less frequent monitoring of hormonal levels in the blood. Also, it reduces the trauma of having to endure OHSS in previous IVFs. (Tabel 2)
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